Status:
COMPLETED
Effects of Cholinergic Augmentation on Measures of Balance and Gait
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
Michael J. Fox Foundation for Parkinson's Research
Conditions:
Parkinson's Disease
Eligibility:
All Genders
30+ years
Phase:
PHASE2
Brief Summary
This study will compare the effects of placebo and donepezil, a drug that helps conserve concentrations of the neurotransmitter, acetylcholine, on measures of balance and gait in subjects with Parkins...
Eligibility Criteria
Inclusion
- 30 years old or older
- Diagnosis of idiopathic Parkinson's disease
- Stand unassisted (without use of an assistance device) and walk continuously for at least 2 minutes.
Exclusion
- musculoskeletal disorders that affect standing and walking
- Uncorrected vision disturbance
- Vestibular problems
- Major depression
- Hallucinations or other psychiatric disturbances
- Tachycardia
- Bradycardia
- Arrhythmias
- Peptic ulcer disease
- Use of anticholinergics
- Use of cholinesterase inhibitors
- Use of bladder antispasmodics
- Use of tricyclic antidepressants
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT02206620
Start Date
July 1 2014
End Date
July 1 2017
Last Update
November 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239-3098